Dong Hwan Kim

Assessment of IL-6, IL-8 and TNF-α levels in the gingival tissue of patients with periodontitis

Young Guk Park, M. Jung, Min-ki Noh, 2013, Experimental and therapeutic medicine.

Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease.

Da Un Jeong, Yinglan Jin, Yongseok Choi, 2022, European journal of medicinal chemistry.

IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria

Su Jin Lee, Keun Woo Lee, J. You, 2021, Scientific Reports.

Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice

S. Reddy, Angélique Quartier, P. Eftekhari, 2023, Biomolecules.

Vutiglabridin improves neurodegeneration in MPTP-induced Parkinson’s disease mice by targeting mitochondrial paraoxonase-2

Y. Pak, H. Park, Sora Kang, 2022, bioRxiv.